Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA.
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA,
Prog Neurol Surg. 2020;35:162-169. doi: 10.1159/000509909. Epub 2020 Sep 29.
Motor cortex stimulation (MCS) has been used in the treatment of intractable neuropathic facial pain for nearly 30 years. While efficacy rates have been noted as high as 88% in some studies, considerable variability in treatment response remains. Additionally, MCS is often cited as providing diminishing relief over time, and there are few long-term studies on efficacy. Complications are generally mild and include infection, hardware complication, seizure, and transient neurological deficit. Despite relatively minimal use, MCS remains a viable treatment option for the appropriately selected facial pain patients that have proved refractory to conservative management.
经颅磁刺激（MCS）已应用于治疗难治性神经性面部疼痛近 30 年。尽管一些研究报道的疗效高达 88%，但治疗反应仍存在较大差异。此外，MCS 的缓解作用往往随时间逐渐减弱，且关于疗效的长期研究较少。并发症通常较轻，包括感染、硬件并发症、癫痫发作和短暂性神经功能缺损。尽管 MCS 的应用相对较少，但对于经保守治疗无效的合适选择的面部疼痛患者，MCS 仍然是一种可行的治疗选择。
